Skip to content

Effectiveness of Shilajatu & Dhatrinisha in Diabetes Mellitus (Prameha)

Open randomised comparative clinical study of Shilajatu & Dhatrinisha in management of Prameha with special reference to Diabetes Mellitus Type II - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/07/054911
Enrollment
60
Registered
2023-07-06
Start date
Unknown
Completion date
Unknown
Last updated
2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

None listed

Sponsors

K.G.Mittal Ayurved College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Fasting blood sugar level = 126 mg/dl and = 250 mg/dl 2. Post prandial blood sugar = 150 mg/dl and = 350 mg/dl 3. HbA1c level between 5.7 % to 10.5% 4. Diagnosed case of Type 2 Diabetes mellitus with 2 years of onset.

Exclusion criteria

Exclusion criteria: 1. Patients of Type I Diabetes mellitus 2. Patient who is taking insulin. 3. Age below 18 years and above 65 years. 4. Fasting blood sugar level = 126 mg/dl and = 250 mg/dl 5. Post prandial blood sugar = 150 mg/dl and = 350 mg/dl 6. HbA1c level below 5.7 % and more than 10.5% 7. Malignant conditions and patients with systematic disease like AIDS, HIV, Crohn’s disease 8. Patients having serum Creatinine more than 2.5 mg/dL and patients on dialysis. 9. Pregnant and lactating mother. 10. Any other patients not fit for trial.

Design outcomes

Primary

MeasureTime frame
Shilajatu and Dhatrinisha are effective in reducing HbA1c levelTimepoint: Baseline and after 3 months

Secondary

MeasureTime frame
Shilajatu & Dhatrinisha are effective in reducing the HbA1c levelTimepoint: 90 days

Countries

India

Contacts

Public ContactDr Arvind Singh

Maharashtra University of Health Sciences, Nashik

spatildr@gmail.com9833341199

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026